OptraScan

Executive Summary

OptraScan is a pioneering digital pathology company based in San Jose, California, founded in 2015. It offers a comprehensive suite of digital slide scanners, image management software, and AI-powered analytics tools designed to modernize pathology workflows. By enabling the transition from traditional microscopy to digital diagnostics, OptraScan aims to improve accuracy, efficiency, and accessibility in pathology services for clinical diagnostics, research, and education. The company operates at the intersection of digital health, AI/ML, and diagnostics, positioning itself as a key player in the growing digital pathology market. With a focus on end-to-end solutions, OptraScan's technology supports high-throughput scanning, secure image storage, and AI-driven analysis for applications such as cancer detection, rare disease identification, and remote consultation. Despite being a private company with undisclosed funding and valuation, OptraScan has established a presence in the competitive landscape and continues to expand its offerings through innovation and strategic partnerships. The company's commitment to digital transformation in pathology positions it well for future growth as healthcare systems increasingly adopt digitized workflows.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for AI-based diagnostic algorithm60% success
• Q2 2027Major partnership with a top-10 US hospital system for digital pathology deployment50% success
• Q1 2027Series B funding round led by prominent healthcare VC70% success